De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR-Reference-Cited by-同舟云学术

De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR

Published:2008-02-12 Issue:5 Volume:83 Page:1230-1239
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Kang Johnthomas,Huddleston Stephen J.,Fraser Joanne M.,Khoruts Alexander

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Reference63 articles.

1. Thymus and autoimmunity: production of CD25+CD4+naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance;Itoh;J. Immunol.,1999

2. Thymic selection of CD4+CD25+regulatory T cells induced by an agonist self-peptide;Jordan;Nat. Immunol.,2001

3. Developmental regulation of Foxp3 expression during ontogeny;Fontenot;J. Exp. Med.,2005

4. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells;Bensinger;J. Exp. Med.,2001

5. Origin and T cell receptor diversity of Foxp3+CD4+CD25+T cells;Pacholczyk;Immunity,2006

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-intensity pulsed ultrasound protects from inflammatory dilated cardiomyopathy through inciting extracellular vesicles;Cardiovascular Research;2024-05-02

2. Fatty acid metabolism of immune cells: a new target of tumour immunotherapy;Cell Death Discovery;2024-01-20

3. The mTOR signalling in corneal diseases: A recent update;Biochemical Pharmacology;2023-07

4. The case for the therapeutic use of mechanistic/mammalian target of rapamycin (mTOR) inhibitors in xenotransplantation;Xenotransplantation;2023-04-07

5. T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches;International Immunopharmacology;2023-01